Momentum Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Momentum Bioscience's estimated annual revenue is currently $1.4M per year.
- Momentum Bioscience's estimated revenue per employee is $84,000
Employee Data
- Momentum Bioscience has 17 Employees.
- Momentum Bioscience grew their employee count by 0% last year.
Momentum Bioscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Office Manager | Reveal Email/Phone |
2 | Principal Development Scientist | Reveal Email/Phone |
3 | Senior Development Scientist | Reveal Email/Phone |
4 | Quality & Compliance Consultant | Reveal Email/Phone |
5 | Principal Development Scientist | Reveal Email/Phone |
6 | Research Technician | Reveal Email/Phone |
7 | Development Scientist | Reveal Email/Phone |
Momentum Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Momentum Bioscience?
Momentum Bioscience is focused on developing rapid tests for bloodstream infection in patients suspected of sepsis. SepsiSTAT® is our direct-from-blood, rapid screening technology, providing actionable results for suspected sepsis patients. SepsiSTAT® contains our three proprietary capabilities: 1. Sensitive and universal microbial capture 2. Universal detection of viable microorganisms 3. Organism profiling Only by using Momentum's proprietary universal pathogen capture, detection & identification capabilities can all patients suspected of sepsis expect actionable results for bloodstream infection in
keywords:N/A
N/A
Total Funding
17
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Momentum Bioscience News
Given a coming in-house Covid-19 vaccine, global production momentum should kick in from 2Q22. 1Q22 earnings preview. Although adhering to a Buy...
... Notebook: University-affiliated innovation districts gain momentum ... The growth and capital in sectors like bioscience are fueling new...
The biosciences community in the Chicago area continues to ... to support and advance the momentum of the community's continued growth.
Other Companies in Cardiff
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 17 | 21% | N/A |
#2 | $2.6M | 17 | -23% | N/A |
#3 | $1.6M | 18 | -50% | N/A |
#4 | $3.8M | 20 | 0% | N/A |
#5 | $2.5M | 22 | 5% | N/A |